Targeting lactate metabolic pathways and blocking lactate transporters such as MCT1 and MCT4 can restrict tumor cell efflux of lactate and inhibit glycolysis, potentially conferring anti-tumor effects (99). Here, SLC16A3 is linked to neoplasm.